Home LiteratureArticle Details
PMID: 15152062 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S. Review

New drugs for rheumatoid arthritis.

The New England journal of medicine ·Vol. 350 ·No. 21 ·2004-05-20 ·Pages 2167-79

Olsen NJ, Stein CM

Abstract

暂无摘要

MeSH Terms
Adalimumab Antibodies, Monoclonal/adverse effects,therapeutic use Antibodies, Monoclonal, Humanized Antirheumatic Agents/adverse effects,therapeutic use Arthritis, Rheumatoid/drug therapy,immunology Etanercept Female Humans Immunoglobulin G/adverse effects,therapeutic use Infliximab Interleukin 1 Receptor Antagonist Protein Isoxazoles/adverse effects,therapeutic use Leflunomide Pregnancy Receptors, Tumor Necrosis Factor/therapeutic use Sialoglycoproteins/adverse effects,therapeutic use Tumor Necrosis Factor-alpha/antagonists & inhibitors
Chemicals
Antibodies, Monoclonal Antibodies, Monoclonal, Humanized Antirheumatic Agents IL1RN protein, human Immunoglobulin G Interleukin 1 Receptor Antagonist Protein Isoxazoles Receptors, Tumor Necrosis Factor Sialoglycoproteins Tumor Necrosis Factor-alpha Infliximab Adalimumab Leflunomide Etanercept
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Olsen Nancy J
Division of Rheumatology, Vanderbilt University School of Medicine, Nashville, USA.
Stein C Michael
Article Info
Journal
The New England journal of medicine
Abbr.
N Engl J Med
ISSN
1533-4406
DOI
10.1056/NEJMra032906
Published
2004-05-20
Pages
2167-79
Language
English
Region
United States
NLM ID
0255562
Subset
IM
Grants
NHLBI NIH HHS · HL 65082 · United States
NHLBI NIH HHS · HL 67964 · United States
AHRQ HHS · HS1-0384 · United States
Corrections
CommentIn
PMID: 15329436
CommentIn
PMID: 15385669
External Links
PubMed source DOI: 10.1056/NEJMra032906 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2